We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Adtran
ADTN
$798M
| $10.8M | 0.07% |
523,424
+16,015
| +3% | +$310K |
|
277
Amneal Pharmaceuticals
AMRX
$5.72B
| $10.8M | 0.07% |
2,099,934
+436,882
| +26% | +$2.48M |
|
278
Genesco
GCO
$396M
| $10.7M | 0.07% |
168,562
+75,803
| +82% | +$4.11M |
|
|
PENG
279
Penguin Solutions Inc
PENG
$2.76B
| $10.7M | 0.07% |
449,904
+38,620
| +9% | +$931K |
|
280
BioMarin Pharmaceuticals
BMRN
$11.5B
| $10.7M | 0.07% |
128,121
-98,590
| -43% | -$7.82M |
|
281
Celanese
CE
$5.09B
| $10.7M | 0.07% |
70,316
-45,260
| -39% | -$7.19M |
|
282
Arlo Technologies
ARLO
$1.4B
| $10.6M | 0.07% |
1,571,421
+432,565
| +38% | +$2.82M |
|
|
AVTA
283
DELISTED
Avantax, Inc. Common Stock
AVTA
| $10.6M | 0.07% |
612,113
+370,618
| +153% | +$6.09M |
|
284
Pinnacle West Capital
PNW
$12.9B
| $10.6M | 0.07% |
128,828
-145,348
| -53% | -$12.3M |
|
|
NPTN
285
DELISTED
NEOPHOTONICS CORP
NPTN
| $10.6M | 0.07% |
1,034,066
-134,737
| -12% | -$1.42M |
|
|
ARGO
286
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $10.5M | 0.07% |
203,364
+37,080
| +22% | +$2M |
|
|
MCHB
287
Mechanics Bancorp
MCHB
$3.47B
| $10.4M | 0.07% |
256,336
+102,946
| +67% | +$4.44M |
|
288
Stepan Co
SCL
$1.31B
| $10.4M | 0.07% |
86,637
-18,975
| -18% | -$2.48M |
|
289
Sonos
SONO
$1.75B
| $10.4M | 0.07% |
293,967
-900,239
| -75% | -$33.7M |
|
290
Hyster-Yale Materials Handling
HY
$593M
| $10.3M | 0.07% |
141,679
-5,937
| -4% | -$461K |
|
|
ECHO
291
EchoStar
ECHO
$25.5B
| $10.2M | 0.07% |
419,835
-144,289
| -26% | -$3.7M |
|
|
KW
292
DELISTED
Kennedy-Wilson Holdings
KW
| $10.2M | 0.07% |
511,214
+114,349
| +29% | +$2.31M |
|
293
PBF Energy
PBF
$7.29B
| $10.1M | 0.07% |
+661,938
| New | +$10.2M |
|
294
Modine Manufacturing
MOD
$12.8B
| $10.1M | 0.07% |
606,365
+18,857
| +3% | +$309K |
|
295
Nabors Industries
NBR
$1.23B
| $10.1M | 0.07% |
88,058
-3,870
| -4% | -$389K |
|
296
Skywest
SKYW
$4.11B
| $9.98M | 0.07% |
231,808
+23,340
| +11% | +$1.15M |
|
|
WOW
297
DELISTED
WideOpenWest
WOW
| $9.84M | 0.07% |
475,345
+452,877
| +2,016% | +$7.1M |
|
298
Wells Fargo
WFC
$261B
| $9.8M | 0.07% |
216,321
+102,218
| +90% | +$4.56M |
|
299
Par Pacific Holdings
PARR
$3.88B
| $9.73M | 0.07% |
578,535
+94,262
| +19% | +$1.42M |
|
|
NXGN
300
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $9.71M | 0.07% |
585,322
+99,725
| +21% | +$1.79M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.